Anhedonia: Current and future treatments
Abstract Anhedonia is a transdiagnostic domain that leads to poor disorder outcome and low remission rates. This narrative review describes a broad range of interventions targeting anhedonia, including pharmacological, neuromodulatory, behavioral, and lifestyle‐based approaches. Drugs such as vortio...
Saved in:
| Main Author: | Alessandro Serretti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | PCN Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pcn5.70088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anhedonia as a basic syndrome and a target for treatment for depressive disorder
by: G. E. Mazo, et al.
Published: (2019-10-01) -
Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database
by: Hrishikesh Kale, et al.
Published: (2025-07-01) -
Association between sleep disorder and anhedonia in adolescence with major depressive disorder: the mediating effect of stress
by: Xinxin Zhao, et al.
Published: (2024-12-01) -
Establishing content validity of the Dimensional Anhedonia Rating Scale
by: Stephanie Bean, et al.
Published: (2025-03-01) -
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients’ and physicians’ perspectives
by: Mami Kasahara-Kiritani, et al.
Published: (2025-07-01)